語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Anti-Angiogenic Therapy in Ophthalmology
~
SpringerLink (Online service)
Anti-Angiogenic Therapy in Ophthalmology
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Anti-Angiogenic Therapy in Ophthalmology/ edited by Andreas Stahl.
其他作者:
Stahl, Andreas.
面頁冊數:
X, 193 p. 26 illus., 23 illus. in color.online resource. :
Contained By:
Springer Nature eBook
標題:
Ophthalmology. -
電子資源:
https://doi.org/10.1007/978-3-319-24097-8
ISBN:
9783319240978
Anti-Angiogenic Therapy in Ophthalmology
Anti-Angiogenic Therapy in Ophthalmology
[electronic resource] /edited by Andreas Stahl. - 1st ed. 2016. - X, 193 p. 26 illus., 23 illus. in color.online resource. - Essentials in Ophthalmology,1612-3212. - Essentials in Ophthalmology,.
Retinal Vascular Development -- Retinopathy of Prematurity -- Anti-Vascular Endothelial Growth Factor (VEGF) Treatment in Neovascular Age-Related Macular Degeneration: Outcomes and Outcome Predictors -- AREDS Supplementation and the Progression Towards Neovascular Exudative AMD -- VEGF-Inhibition in Macular Telangiectasia Type 2 -- Diabetic Retinopathy -- Retinal Vein Occlusion -- Pharmacokinetics of Intravitreally Applied VEGF Inhibitors -- Neovascular Glaucoma -- Corneal Neovascular Diseases -- Anti‐Angiogenic Gene Therapy - Basic Science and Challenges for Translation into the Clinic.
This book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases.
ISBN: 9783319240978
Standard No.: 10.1007/978-3-319-24097-8doiSubjects--Topical Terms:
644487
Ophthalmology.
LC Class. No.: RE1-994
Dewey Class. No.: 617.7
Anti-Angiogenic Therapy in Ophthalmology
LDR
:02858nam a22004095i 4500
001
977481
003
DE-He213
005
20200702172604.0
007
cr nn 008mamaa
008
201211s2016 gw | s |||| 0|eng d
020
$a
9783319240978
$9
978-3-319-24097-8
024
7
$a
10.1007/978-3-319-24097-8
$2
doi
035
$a
978-3-319-24097-8
050
4
$a
RE1-994
072
7
$a
MJQ
$2
bicssc
072
7
$a
MED063000
$2
bisacsh
072
7
$a
MJQ
$2
thema
082
0 4
$a
617.7
$2
23
245
1 0
$a
Anti-Angiogenic Therapy in Ophthalmology
$h
[electronic resource] /
$c
edited by Andreas Stahl.
250
$a
1st ed. 2016.
264
1
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2016.
300
$a
X, 193 p. 26 illus., 23 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
490
1
$a
Essentials in Ophthalmology,
$x
1612-3212
505
0
$a
Retinal Vascular Development -- Retinopathy of Prematurity -- Anti-Vascular Endothelial Growth Factor (VEGF) Treatment in Neovascular Age-Related Macular Degeneration: Outcomes and Outcome Predictors -- AREDS Supplementation and the Progression Towards Neovascular Exudative AMD -- VEGF-Inhibition in Macular Telangiectasia Type 2 -- Diabetic Retinopathy -- Retinal Vein Occlusion -- Pharmacokinetics of Intravitreally Applied VEGF Inhibitors -- Neovascular Glaucoma -- Corneal Neovascular Diseases -- Anti‐Angiogenic Gene Therapy - Basic Science and Challenges for Translation into the Clinic.
520
$a
This book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases.
650
0
$a
Ophthalmology.
$3
644487
650
0
$a
Angiology.
$3
668966
700
1
$a
Stahl, Andreas.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1109411
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9783319240954
776
0 8
$i
Printed edition:
$z
9783319240961
776
0 8
$i
Printed edition:
$z
9783319795805
830
0
$a
Essentials in Ophthalmology,
$x
1612-3212
$3
1255265
856
4 0
$u
https://doi.org/10.1007/978-3-319-24097-8
912
$a
ZDB-2-SME
912
$a
ZDB-2-SXM
950
$a
Medicine (SpringerNature-11650)
950
$a
Medicine (R0) (SpringerNature-43714)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入